Skip to main content
. 2017 May 31;8:229. doi: 10.3389/fneur.2017.00229

Table 3.

Associations between regions and other covariates with physical and mental health quality of life (QOL) obtained using multivariable linear regression models.

Variables Physical QOL (n = 1,602)a
Mental health QOL (n = 1,766)b
Mean differences (95% CI) p-Value Mean differences (95% CI) p-Value
Region Australasia Reference Reference
Europe −2.88 (−6.41, 0.65) 0.110 0.27 (−3.52, 4.06) 0.888
North America −1.24 (−3.46, 0.98) 0.273 −0.96 (−3.36, 1.43) 0.431

Sociodemographic factors

Gender Male Reference Reference
Female 0.67 (−1.54, 2.89) 0.550 1.37 (−1.09, 3.83) 0.276
Age (10 years) −1.37 (−2.36, −0.38) 0.007 3.05 (1.94, 4.16) <0.001

Marital status Married/cohabiting/partnered Reference
Single −2.81 (−5.62, −0.01) 0.049
Separated/divorced/widower −3.26 (−6.27, −0.24) 0.034

Employment status Employed full or part time Reference Reference
Student or stay at home carer −1.00 (−3.77, 1.77) 0.478 −1.43 (−4.48, 1.61) 0.356
Unemployed −6.29 (−9.69, −2.88) <0.001 −9.90 (−13.54, −6.26) <0.001
Retired due to age or disability −13.20 (−15.49, −10.92) <0.001 −7.11 (−9.61, −4.62) <0.001

Education level No school/primary/secondary Reference Reference
Vocational training 0.89 (−1.76, 3.55) 0.510 1.30 (−1.57, 4.17) 0.374
Bachelor degree 3.66 (1.40, 5.93) 0.002 1.73 (−0.71, 4.17) 0.164
Postgraduate 3.08 (0.57, 5.59) 0.016 2.20 (−0.52, 4.92) 0.113

Disease characteristics

Years since diagnosis (quartiles) Less than 3 years Reference Reference
4–6 years 0.35 (−2.05, 2.75) 0.775 −0.37 (−2.98, 2.24) 0.781
7–12 years −2.96 (−5.36, −0.56) 0.016 −1.14 (−3.76, 1.48) 0.392
13 years and above −2.82 (−5.40, −0.23) 0.033 −1.38 (−4.24, 1.47) 0.343

Type of MS Relapsing-remitting Reference
Primary progressive −2.28 (−6.11, 1.54) 0.242
Secondary progressive −2.99 (−6.23, 0.25) 0.070
Progressive relapsing −5.50 (−12.24, 1.24) 0.109
Benign 5.37 (0.59, 10.16) 0.028
Unsure/other −1.88 (−4.69, 0.94) 0.191

Current disease modifying medication use No current DMD use Reference Reference
Less than 12 months −2.53 (−5.07, 0.02) 0.052 −3.24 (−6.03, −0.44) 0.023
More than 12 months −1.14 (−3.03, 0.76) 0.240 −1.96 (−4.11, 0.20) 0.075

Modifiable lifestyle factors

Smoking status Never Reference Reference
Former −0.87 (−2.66, 0.92) 0.339 −2.30 (−4.22, −0.37) 0.020
Current −7.77 (−10.61, −4.93) <0.001 −7.14 (−10.27, −4.02) <0.001

Alcohol consumption Low Reference Reference
Moderate and high 3.66 (1.91, 5.41) <0.001 2.42 (0.52, 4.32) 0.013

Physical activity level Low Reference Reference
Moderate 9.39 (7.37, 11.42) <0.001 4.53 (2.33, 6.72) <0.001
High 15.05 (12.93, 17.18) <0.001 6.97 (4.63, 9.30) <0.001

Vitamin D supplementation None Reference Reference
1–5,000 IU −0.45 (−2.87, 1.97) 0.714 0.99 (−1.63, 3.61) 0.458
>5,000 IU 0.64 (−2.26, 3.55) 0.665 1.77 (−1.39, 4.92) 0.272

Omega 3 supplementation type None Reference Reference
Fish oil 1.79 (−0.32, 3.89) 0.096 0.62 (−1.66, 2.89) 0.594
Flaxseed oil 3.10 (−0.18, 6.37) 0.064 1.44 (−2.09, 4.97) 0.424
Both fish oil and flaxseed oil 3.04 (0.33, 5.75) 0.028 −0.29 (−3.19, 2.60) 0.842

Meditation frequency Never Reference Reference
Less than once per week −1.36 (−3.48, 0.77) 0.212 −2.59 (−4.88, −0.30) 0.027
1–4 times per week −2.23 (−4.62, 0.16) 0.068 0.21 (−2.37, 2.79) 0.874
5 or more times per week −1.52 (−4.46, 1.43) 0.313 2.56 (−0.66, 5.77) 0.119

Social support 0 or 1 support person Reference Reference
2 or more support people 4.42 (2.52, 6.32) <0.001 7.15 (5.10, 9.19) <0.001

Body mass index (kg/m2) Normal Reference Reference
Underweight 2.22 (−2.05, 6.49) 0.309 2.38 (−2.11, 6.87) 0.298
Overweight −3.03 (−5.14, −0.91) 0.005 −3.24 (−5.54, −0.94) 0.006
Obese −5.74 (−8.08, −3.40) <0.001 −4.50 (−7.03, −1.98) <0.001

Dietary habits score (10 U) 2.05 (1.16, 2.94) <0.001 2.23 (1.27, 3.20) <0.001

Latitude (10°) −0.69 (−2.33, 0.95) 0.407 −1.24 (−3.03, 0.56) 0.176

Complete case analysis was used.

aAnalyses consisted of 66.7% participants. Marital status was not included as a covariate in the model as it is not directly associated with physical quality of life (26), and type of MS was not considered to be confounders in this model.

bAnalyses consisted of 73.6% participants.